Sanibel Captiva Trust Company Inc. Sells 1,467 Shares of Humana Inc. (NYSE:HUM)

Sanibel Captiva Trust Company Inc. reduced its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 45.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,745 shares of the insurance provider's stock after selling 1,467 shares during the quarter. Sanibel Captiva Trust Company Inc.'s holdings in Humana were worth $443,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Atlas Brown Inc. lifted its stake in Humana by 0.6% during the fourth quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock valued at $1,611,000 after purchasing an additional 38 shares during the last quarter. Moors & Cabot Inc. increased its holdings in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider's stock valued at $519,000 after buying an additional 40 shares in the last quarter. OLD National Bancorp IN lifted its position in shares of Humana by 1.8% during the 3rd quarter. OLD National Bancorp IN now owns 2,613 shares of the insurance provider's stock valued at $828,000 after acquiring an additional 45 shares during the last quarter. Your Advocates Ltd. LLP boosted its stake in shares of Humana by 81.8% during the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares in the last quarter. Finally, Brooklyn Investment Group grew its holdings in shares of Humana by 6.7% in the 3rd quarter. Brooklyn Investment Group now owns 736 shares of the insurance provider's stock worth $233,000 after acquiring an additional 46 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HUM has been the subject of several analyst reports. Sanford C. Bernstein raised Humana from a "market perform" rating to an "outperform" rating and set a $308.00 target price for the company in a report on Tuesday, October 8th. Morgan Stanley raised their target price on shares of Humana from $288.00 to $301.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Piper Sandler lifted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Humana from $349.00 to $250.00 and set a "hold" rating for the company in a research report on Thursday, October 3rd. Finally, Royal Bank of Canada lowered their price objective on shares of Humana from $400.00 to $265.00 and set an "outperform" rating on the stock in a research report on Tuesday, October 8th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Humana has an average rating of "Hold" and a consensus price target of $302.70.

Humana Stock Up 2.5 %

Shares of HUM stock traded up $6.83 on Monday, hitting $282.63. The company's stock had a trading volume of 1,829,765 shares, compared to its average volume of 1,581,703. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market capitalization of $34.03 billion, a price-to-earnings ratio of 25.03, a P/E/G ratio of 2.02 and a beta of 0.55. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $415.73. The firm's fifty day moving average price is $273.81 and its 200-day moving average price is $307.18.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The company had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Research analysts anticipate that Humana Inc. will post 16.14 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.25%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana's payout ratio is 31.36%.

Insider Buying and Selling

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.29% of the stock is owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.